Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.53 |
| ▸ | MAOA | P21397 | 3/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL486858 | 0.90 | MAOB (0.59) | MAOBMAOACYP19A1CA1CA2 | |
| SCHEMBL9253121 | 0.89 | MAOB (0.55) | MAOBMAOACYP19A1CA1CA2 | |
| SCHEMBL28158901 | 0.82 | MAOB (0.52) | MAOBMAOACYP19A1CA1CA2 | |
| SCHEMBL27369620 | 0.81 | HSPA5 (0.54) | MAOBMAOACYP19A1CA1CA2 | |
| SCHEMBL7730754 | 0.81 | DHFR (0.54) | CA1CA2CA9CYP3A4BCL2 | |
| SCHEMBL5718444 | 0.81 | PNMT (0.52) | CYP3A4SIGMAR1 | |
| SCHEMBL27272716 | 0.81 | HTR2A (0.36) | MAOBMAOACYP3A4HTR2APOLB | |
| SCHEMBL542553 | 0.81 | HTR2A (0.56) | MAOBMAOACYP3A4CASP1HTR2A | |
| SCHEMBL49433 | 0.80 | MAOB (0.62) | MAOBMAOACYP19A1CA1CA2 | |
| SCHEMBL30583096 | 0.80 | MAOB (0.62) | MAOBMAOACYP19A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240110002-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | INGEVITY UK LTD (GB) | 2024-04-04 | — | — | US | claimed |
| CN-114805802-B | Benzoxazine-terminated imide, preparation method thereof and polybenzoxazine-terminated imide film | 华南理工大学 | 2023-08-22 | — | — | CN | claimed |
| CN-118043732-A | Weak anchoring liquid crystal aligning agent, liquid crystal display element and polymer | 日产化学株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-117925256-A | Liquid crystal alignment agent, method for producing same, liquid crystal alignment film, and liquid crystal display element | 奇美实业股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240110002-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | INGEVITY UK LTD (GB) | 2024-04-04 | — | — | US | disclosed |
| WO-2024058164-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-03-21 | — | — | WO | disclosed |
| CN-117460990-A | Weak anchoring liquid crystal aligning agent, liquid crystal display element and copolymer | 日产化学株式会社 | 2024-01-26 | — | — | CN | disclosed |
| CN-116997854-A | Liquid crystal composition, method for manufacturing liquid crystal display element, and liquid crystal display element | 日产化学株式会社 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023171690-A1 | WEAK-ANCHORING LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023157879-A1 | WEAK-ANCHORING LIQUID CRYSTAL ALIGNING AGENT, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023140322-A1 | WEAK-ANCHORING LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CYRSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-07-27 | — | — | WO | disclosed |
| WO-2006104528-A1 | DIIMINES AND SECONDARY DIAMINES | ALBEMARLE CORPORATION (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060217567-A1 | Diimines and secondary diamines | ALBEMARLE CORPORATION | 2006-09-28 | — | — | US | disclosed |
| US-7030170-B2 | Photosensitive resin composition, dry film, and workpiece using the same | MITSUI CHEMICALS, INC. (JP) | 2006-04-18 | — | — | US | disclosed |
| US-20030176528-A1 | Photosensitive resin composition, dry film, and workpiece using the same | MITSUI CHEMICALS, INC. (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-0257011-B1 | PERMEATION MODIFIED ASYMMETRIC GAS SEPARATION MEMBRANES HAVING GRADED DENSITY SKINS | PERMEA, Inc. (US) | 1992-10-07 | — | — | EP | disclosed |
| US-4792404-A | USING CHLORINE-RESISTANT POLYAMIDE MEMBRANE | ALLIED-SIGNAL INC. (US) | 1988-12-20 | — | — | US | disclosed |
| US-4728346-A | PERMSELECTIVITY | PERMEA INC. (US) | 1988-03-01 | — | — | US | disclosed |
| EP-0257011-A2 | Permeation modified asymmetric gas separation membranes having graded density skins | PERMEA, Inc. (US) | 1988-02-24 | — | — | EP | disclosed |
| US-4575385-A | POLYSULFONES CONTACTED WITH BENZENE COMPOUND | MONSANTO COMPANY (US) | 1986-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217567-A1 | Diimines and secondary diamines | DDT, DDC, AOC1 | MAOB 207/4885MAOA 145/4885CYP19A1 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.